Company news: Amylin vs. Lilly; CVS Caremark

Share this article:
Amylin was granted a temporary restraining order against Eli Lilly & Co. preventing Lilly from going forward with plans to have the same reps detail both Byetta, which it co-promotes with Amylin, and Boehringer Ingelheim's rival type 2 diabetes drug Tradjenta in the US.

The authors of a study of medication adherence that included researchers from Harvard, Brigham and Women's Hospital and CVS Caremark issued their conclusions, calling for: the development of tools allowing prediction and targeting of patients at-risk for non-adherence and prescription abandonment; adoption of a “pharmacy home” concept to simplify care for patients with complex therapies; individualized counseling by pharmacists and healthcare providers; research on the use of financial and other incentives to encourage adherence; a “personalized medicine” approach for pharmacies through pharmacogenomics or individualized counseling with pharmacists; and the use of social networks to improve adherence through family and friends.  
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.